The active targeting of the developed nanocomplexes to VCAM-1 and IL4Rα receptors were used as an effective therapeutic and diagnostic tool for murine breast cancer using noninvasive bioluminescence and Magnetic Resonance (MR) imaging. Here, VCAM1 is linked to breast cancer.